Capital Investment Advisory Services’s Fibrocell Science Inc. FCSC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-8
Closed 1409
2019
Q3
$0 Hold
8
﹤0.01% 1511
2019
Q2
$0 Hold
8
﹤0.01% 1492
2019
Q1
$0 Hold
8
﹤0.01% 1315
2018
Q4
$0 Buy
+8
New +$16 ﹤0.01% 1239

Capital Investment Advisory Services's FCSC Position: Q4 2019 in Review

Capital Investment Advisory Services sold out of Fibrocell Science Inc. (FCSC) in Q4 2019, closing a stake of 8 shares.

Capital Investment Advisory Services first reported a position in FCSC in Q4 2018 and held it in 4 quarters. The position peaked at $0 in Q3 2019. 0 funds tracked by Wall St. Rank hold FCSC as of Q4 2019.

  • Capital Investment Advisory Services reported no remaining Fibrocell Science Inc. position as of Q4 2019 after selling out during the quarter.
  • Capital Investment Advisory Services sold 8 Fibrocell Science Inc. shares in Q4 2019.
  • Capital Investment Advisory Services first reported a position in Fibrocell Science Inc. in Q4 2018 and held it in 4 quarters.
  • Capital Investment Advisory Services's Fibrocell Science Inc. position peaked at $0 in Q3 2019.
  • 0 funds tracked by Wall St. Rank held Fibrocell Science Inc. as of Q4 2019.

Based on Capital Investment Advisory Services's 13F filing for Q4 2019, filed 4 Feb 2020.